Karteek Sandadi
About Karteek Sandadi
Karteek Sandadi serves as the Senior Director of Global Regulatory Operations at BridgeBio, where he oversees business systems. He has extensive experience in regulatory operations, pharmacovigilance, and the global deployment of regulatory enterprise systems, having held various leadership roles in prominent companies such as Veeva Systems and EXTEDO.
Work at BridgeBio
Karteek Sandadi currently serves as the Senior Director of Global Regulatory Operations, Business Systems at BridgeBio. He has held this position since 2024, working remotely. In this role, he is responsible for overseeing regulatory operations and business systems on a global scale.
Previous Experience at Veeva Systems
Prior to his current role, Karteek Sandadi worked at Veeva Systems from 2018 to 2024. His positions included Senior Consultant, R&D Services, from 2018 to 2019, Team Lead, R&D Services, from 2019 to 2020, and Practice Manager, R&D Services, from 2020 to 2024. His tenure at Veeva Systems involved managing various aspects of research and development services.
Career at EXTEDO
Karteek Sandadi held multiple roles at EXTEDO between 2013 and 2018. He served as Associate Director of Global Professional Services from 2013 to 2015, Director of Global Professional Services from 2015 to 2017, and Associate Vice President of Global Professional Services from 2017 to 2018. His work focused on regulatory compliance and professional services in the pharmaceutical sector.
Educational Background
Karteek Sandadi earned a Master's degree in Electrical Engineering from the University of Missouri-Kansas City, completing his studies from 2006 to 2008. This educational background has contributed to his expertise in regulatory operations and systems integration.
Expertise in Regulatory Operations
Karteek Sandadi possesses extensive expertise in the global deployment of regulatory enterprise systems. His skills include component publishing and validation processes, which are essential for ensuring compliance with regulatory standards. He also has a strong background in pharmacovigilance, focusing on the safety of pharmaceutical products.